Latest news LIVE: Rahul Gandhi to launch Cong’s ‘Bharat Jodo Yatra’ today
[ad_1]
The Drugs Controller General of India (DCGI) on Tuesday approved the country’s first intra-nasal Covid-19 vaccine — Bharat Biotech’s iNCOVACC — for restricted emergency use in those aged above 18 years. It’s only the second such vaccine in the world, after CanSino Biologics’ vaccine in China, to get regulatory approval. Around 100 mucosal (nose and mouth) Covid-19 vaccines are under development across the world.
[ad_2]
Source link
Comments are closed.